Neurostimulation Devices Market Size and Forecasts (2020 – 2030)

Neurostimulation Devices Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, and Others), Application (Pain Management, Epilepsy, Urinary and Fecal Incontinence, Parkinson’s Disease, and Others), End User (Hospitals, Specialty Clinics, and Others), and Geography

Send Enquiry
Item ID: TIPRE00002778 Category: Tags: , ,

$3,185$5,985

Description

The neurostimulation devices market is projected to reach US$ 11.825 billion in 2030 from US$ 5.802 billion in 2022. The market is estimated to grow with a CAGR of 9.3% from 2022 to 2030. The growing prevalence of neurological diseases and increasing cases of spinal cord injury are the key driving factors behind the neurostimulation devices market development. However, lack of expert professionals is hampering the neurostimulation devices market growth.

Rising Demand for Noninvasive Treatment to Boost the Neurostimulation Devices Market in Future

Neurostimulation is a rapidly evolving field that uses targeted electrical, mechanical, magnetic, or thermal stimulation of the nervous system to alter the properties of firing neuronal and internal neuronal connectivity to treat various neurological disorders. Noninvasive neurostimulation devices include electroconvulsive therapy (ECT), transcutaneous electrical nerve stimulation (TENS), transcranial electrical stimulation (TES), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), static magnetic stimulation, random sound stimulation, peripheral nerve stimulation, ultrasound, and focused ultrasound (FUS), including cranial nerve stimulation. Noninvasive neurostimulation techniques are the most developed in psychiatry.

Patients and healthcare providers increasingly prefer noninvasive or minimally invasive treatment options as they are convenient, painless, safe, and have minimal side effects. In addition, it is widely used in neurological diseases. Noninvasive treatments aim to improve the quality of life and reduce the impact of speech, swallowing, and cognitive problems. Therefore, growing demand for noninvasive treatments would significantly fuel the neurostimulation devices market growth in the future.

The government is educating people about stroke and offering improved treatment, medical technology, and enhanced healthcare coverage and healthcare environment. Also, the country has invested more in preventing and treating noncommunicable diseases. Additionally, as per the data of WHO, ~95% of the population of China is insured in rural and urban areas, as the government introduced two insurance programs for low-income groups: the New Rural Cooperative Medical System (NRCMS) and Urban Resident Basic Medical Insurance (URBMI). The programs were launched as the cost of health is one of the significant expenses for most of the population. These initiatives by the Chinese government would encourage the population to undergo surgeries to improve health. The neurostimulation devices market is also expected to grow due to the rising development of the medical device industry in countries such as Japan and China. In addition, innovative technology trends in neurology and the rapid adoption of artificial intelligence (AI) and machine learning (ML) are a few factors that drive the market in the region.

Furthermore, the neurostimulation devices market growth in the country is attributed to the rising prevalence of stroke and increasing incidence. Neurosurgery requires advanced equipment and highly qualified medical professionals. Germany has highly qualified neurosurgeons; they follow the latest protocols and surgical procedures. Neurology centers in the country have the most modern diagnostic and minimally invasive surgical devices that meet international quality standards.

According to the data published in the Burden of Stroke in Europe report conducted by King’s College London for the Stroke Alliance for Europe, Germany records around 88,922 stroke cases annually, which is 51.7 strokes per 100,000 inhabitants. The prevalence of stroke in Germany was ? 526,774 that accounts for 338.5 strokes per 100,000 residents. Germany also has a significant mortality rate of stroke, i.e., 75,861 deaths due to stroke per year. According to the Burden of Stroke in Europe report, it is expected that stroke cases will increase by 30% by 2035, and the prevalence of stroke will grow to 19% by the end of 2035.approximately 400,000 people were affected with the disease in Germany in December 2022, and the numbers are increasing due to demographic aging. More and more people, including younger people, suffer from neurodegenerative diseases; in Germany, more than 2 million people have dementia or Parkinson’s. According to the German Association for Alzheimer’s Patients, in 2020, 9,450 deaths were caused due to Alzheimer’s, recording the highest figure. The increase in hospitalizations and deaths with Alzheimer’s diagnosis is highly dependent on the aging population in Germany. In Germany, people aged 65 and above had increased by ~33% and reached 18.3 million in 2020.

Thus, significantly growing incidence of stroke and rising aging population resulting in growing cases of neurological disorders drive the neurostimulation devices market growth in Germany. Furthermore, supportive government initiatives and research in neurology also boost market growth. Therefore, the factors mentioned above are likely to contribute to the neurostimulation devices market growth during 2022-2030.

The neurostimulation devices market is segmented on the basis of product, application, end user, and geography. Based on product, the market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during 2022-2030. The neurostimulation devices market, by application, is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson’s disease, and others. The pain management segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during 2022-2030. The neurostimulation devices market, by end user, is bifurcated into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the market in 2022 and specialty clinics segment is anticipated to register the highest CAGR in the market during 2022-2030. Specialty clinics are centers of excellence assured to deliver high standards of clinical outcomes. These centers are dedicated to diagnosing, treating, and managing neurological disorders and employ highly trained doctors, paramedics, and nursing personnel with specialized skills. Besides adhering to predefined protocols using high-end equipment, better service quality adds value to patients more than other facilities. These clinics streamline services and enhance convenient care.

In addition, specialty clinics provide medically recommended and supervised treatments in a relaxing and calming environment. These clinics also help to educate people regarding daily care routines for patients who have Parkinson’s disease and Alzheimer’s disease, tremors, and other such conditions, apart from providing several diagnostic procedures. These patients might undergo testing of motor symptoms by taking medications with gaps to assess the disease severity. Factors such as cost-effectiveness and shorter waiting times fuel the segment growth.

A global rise in the prevalence of these conditions has led to a growing number of patients visiting specialty clinics to diagnose and treat these conditions, with an increasing number of specialty clinics on the global level that offer better treatment and specialized services. In addition, the market growth is attributable to the growing penetration rate of specialty clinics across the globe. For instance, in July 2022, the neurology teams of Ohio State University Wexner Medical Center opened a new specialty clinic, the Parkinson’s Disease Multidisciplinary Clinic. The clinic acts as a “one-stop shop” for Parkinson’s disease patients to receive all the care they need without taking multiple appointments in different locations. At the clinic, patients can address symptoms such as stiffness, memory difficulties, unsteadiness/poor coordination, tremors, and fatigue with a team that includes therapists, neuropsychologists, subspecialty-trained movement neurologists, and advanced practice providers.

The Food and Drug Administration (FDA), National Cancer Institute (NCI), Ministry of Health and Prevention (MoHAP), and National Transformation Program (NTP) are among some of the primary and secondary sources referred to while preparing the report on the neurostimulation devices market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

Oncology Segment, by Disease Indication to Account Larger Share in Neurostimulation Devices Market during 2022–2030

According to our latest study on “Neurostimulation Devices Market Forecast to 2030 – COVID-19 Impact and Global Analysis – Product, Application, and End User,” the market is expected to grow from US$ 5,802.47 million in 2022 and is expected to reach a value of US$ 11,825.95 million by 2030; it is anticipated to record a CAGR of 9.3% from 2022 to 2030. The report highlights the key factors driving the neurostimulation devices market growth and prominent players with their developments in the market.

Neurostimulation devices attach electrodes to the brain, spinal cord, or peripheral nerves. Each device can collect and store data over time, and the nature of this data reflects the different therapeutic strategies used. Neuromodulation uses electrical or magnetic pulsations to influence or stimulate the central or peripheral pain pathways. This procedure aims to control the pain systems to minimize pain levels. Neurostimulation devices can be used safely and effectively to treat drug-resistant epilepsy. Rapid advances in neurostimulation technology relieve the patients affected by neurological and psychiatric disorders. Neurostimulation therapies include invasive and noninvasive approaches in which electrical stimulation drives neuronal function within a circuit.

The neurostimulation devices market, by application, is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson’s disease, and others. The pain management segment held the largest market share in 2022 and same segment is anticipated to register the highest CAGR of 9.9% during the forecast period. Per the US Centers for Disease Control and Prevention (CDC), back pain is the second leading reason for hospital visits, and ~60% and 80% of people experience lower back pain during their lifetime, which is one of the major reasons for hospital admission or surgeries. Neurostimulation is a safer and more efficient solution for alleviating chronic pain and is widely adopted. Numerous biotech companies are launching neurostimulators to help opioid addicts overcome pain and other withdrawal symptoms. For example, in April 2021, Spark Biomedical, a leading medical device company, rolled out a new neurostimulation device called Sparrow Therapy System to help opioid addicts work through withdrawal symptoms. The device uses low doses of electricity to stimulate endorphin production, which helps to alleviate the pain and fear that patients experience during withdrawal. In January 2023, the FDA approved Abbott’s Proclaim XR spinal cord neurostimulation system, which supports patients with diabetic peripheral neuropathy to manage chronic pain. Thus, the segment is expected to grow due to the application and benefits of neurostimulation devices during the forecast period.

Medtronic Plc; Boston Scientific Corp; Abbott Laboratories; Nevro Corp; LivaNova Plc; Synapse Biomedical Inc.; Nalu Medical, Inc.; ElectroCore Inc.; MicroTransponder Inc; and Mainstay Medical are among the leading companies operating in the global neurostimulation devices market.

Companies operating in the neurostimulation devices market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the neurostimulation devices market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall neurostimulation devices market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

A few of the significant developments by key market players are listed below.

• In August 2023, Abbott announced that the U.S. Food and Drug Administration (FDA) had approved its new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy. The next generation of Abbott’s proprietary BurstDR stimulation, FlexBurst360 therapy, offers pain coverage across six areas of the trunk and/or limbs. It enables programming that can be adjusted as a person’s therapeutic needs evolve.

• In August 2023, Mainstay Medical Holdings plc announced the completion of enrollment in its RESTORE randomized clinical study of ReActiv8 for the treatment of intractable chronic low back pain. The study provided a direct comparison for optimizing medical management to test the hypothesis adding ReActiv8 Restorative Neurostimulation therapy to current care paradigms results in significant improvements in back pain-related disability

• In April 2023, Synapse Biomedical, Inc. announced that the FDA approved NeuRx Diaphragm Pacing System (NeuRx DPS) for usage in patients with spinal cord injuries and those who rely on mechanical ventilation.

• In December 2022, Abbott announced that it received approval from the U.S. Food and Drug Administration (FDA) for the Eterna spinal cord stimulation (SCS) system. It is the smallest implantable, rechargeable spinal cord stimulator that is available for treating chronic pain.

• In January 2022, Medtronic plc received the U.S. Food and Drug Administration approval for the Intellis rechargeable neurostimulator and Vanta recharge-free neurostimulator for the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN).

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific HVAC Controls Market Landscape
4.1 Overview
4.2 Ecosystem Analysis
4.2.1 List of Vendors in The Value Chain
5. Asia Pacific HVAC Controls Market – Key Industry Dynamics
5.1 Asia Pacific HVAC Controls Market – Key Industry Dynamics
5.2 Market Drivers
5.2.1 Growth in Construction Sector
5.2.2 Implementation of Smart, Connected, and Energy Efficient IOT-enabled HVAC Systems
5.3 Market Restraints
5.3.1 High Cost and Technical complexities
5.4 Market Opportunities
5.4.1 Rising Adoption of Cloud Computing in HVAC
5.4.2 Development of Smart Cities
5.5 Future Trends
5.5.1 Advancement in Green Technology
5.6 Impact of Drivers and Restraints:
6. HVAC Controls Market – Asia Pacific Market Analysis
6.1 Asia Pacific HVAC Controls Market Revenue (US$ Million), 2022 – 2030
6.2 Asia Pacific HVAC Controls Market Forecast and Analysis
7. Asia Pacific HVAC Controls Market Analysis – Component
7.1 Hardware
7.1.1 Overview
7.1.2 Hardware Market, Revenue and Forecast to 2030 (US$ Million)
7.1.3 Sensor
7.1.3.1 Overview
7.1.3.2 Sensor Market, Revenue and Forecast to 2030 (US$ Million)
7.1.4 Controllers
7.1.4.1 Overview
7.1.4.2 Controllers Market, Revenue and Forecast to 2030 (US$ Million)
7.1.5 Smart Vents
7.1.5.1 Overview
7.1.5.2 Smart Vents Market, Revenue and Forecast to 2030 (US$ Million)
7.1.6 Others
7.1.6.1 Overview
7.1.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
7.2 Software & Services
7.2.1 Overview
7.2.2 Software & Services Market, Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific HVAC Controls Market Analysis – Installation Type
8.1 Retrofit
8.1.1 Overview
8.1.2 Retrofit Market Revenue, and Forecast to 2030 (US$ Million)
8.2 New Installation
8.2.1 Overview
8.2.2 New Installation Market Revenue, and Forecast to 2030 (US$ Million)
9. Asia Pacific HVAC Controls Market Analysis – System
9.1 Temperature Control System
9.1.1 Overview
9.1.2 Temperature Control System Market Revenue, and Forecast to 2030 (US$ Million)
9.2 Integrated Control System
9.2.1 Overview
9.2.2 Integrated Control System Market Revenue, and Forecast to 2030 (US$ Million)
9.3 Ventilation Control System
9.3.1 Overview
9.3.2 Ventilation Control System Market Revenue, and Forecast to 2030 (US$ Million)
9.4 Humidity Control System
9.4.1 Overview
9.4.2 Humidity Control System Market Revenue, and Forecast to 2030 (US$ Million)
10. Asia Pacific HVAC Controls Market Analysis – End User
10.1 Commercial
10.1.1 Overview
10.1.2 Commercial Market Revenue, and Forecast to 2030 (US$ Million)
10.2 Industrial
10.2.1 Overview
10.2.2 Industrial Market Revenue, and Forecast to 2030 (US$ Million)
10.3 Residential
10.3.1 Overview
10.3.2 Residential Market Revenue, and Forecast to 2030 (US$ Million)
11. Asia Pacific HVAC Controls Market – Country Analysis
11.1 Overview
11.1.1 Asia Pacific HVAC Controls Market Revenue and Forecasts and Analysis – By Country
11.1.1.1 Asia Pacific HVAC Controls Market Revenue and Forecasts and Analysis – By Country
11.1.1.2 China HVAC Controls Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.2.1 China HVAC Controls Market Breakdown by Component
11.1.1.2.1.1 China HVAC Controls Market Breakdown by Hardware
11.1.1.2.2 China HVAC Controls Market Breakdown by Installation Type
11.1.1.2.3 China HVAC Controls Market Breakdown by System
11.1.1.2.4 China HVAC Controls Market Breakdown by End User
11.1.1.3 Japan HVAC Controls Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.3.1 Japan HVAC Controls Market Breakdown by Component
11.1.1.3.1.1 Japan HVAC Controls Market Breakdown by Hardware
11.1.1.3.2 Japan HVAC Controls Market Breakdown by Installation Type
11.1.1.3.3 Japan HVAC Controls Market Breakdown by System
11.1.1.3.4 Japan HVAC Controls Market Breakdown by End User
11.1.1.4 South Korea HVAC Controls Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.4.1 South Korea HVAC Controls Market Breakdown by Component
11.1.1.4.1.1 South Korea HVAC Controls Market Breakdown by Hardware
11.1.1.4.2 South Korea HVAC Controls Market Breakdown by Installation Type
11.1.1.4.3 South Korea HVAC Controls Market Breakdown by System
11.1.1.4.4 South Korea HVAC Controls Market Breakdown by End User
11.1.1.5 India HVAC Controls Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.5.1 India HVAC Controls Market Breakdown by Component
11.1.1.5.1.1 India HVAC Controls Market Breakdown by Hardware
11.1.1.5.2 India HVAC Controls Market Breakdown by Installation Type
11.1.1.5.3 India HVAC Controls Market Breakdown by System
11.1.1.5.4 India HVAC Controls Market Breakdown by End User
11.1.1.6 Australia HVAC Controls Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.6.1 Australia HVAC Controls Market Breakdown by Component
11.1.1.6.1.1 Australia HVAC Controls Market Breakdown by Hardware
11.1.1.6.2 Australia HVAC Controls Market Breakdown by Installation Type
11.1.1.6.3 Australia HVAC Controls Market Breakdown by System
11.1.1.6.4 Australia HVAC Controls Market Breakdown by End User
11.1.1.7 Rest of Asia Pacific HVAC Controls Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.7.1 Rest of Asia Pacific HVAC Controls Market Breakdown by Component
11.1.1.7.1.1 Rest of Asia Pacific HVAC Controls Market Breakdown by Hardware
11.1.1.7.2 Rest of Asia Pacific HVAC Controls Market Breakdown by Installation Type
11.1.1.7.3 Rest of Asia Pacific HVAC Controls Market Breakdown by System
11.1.1.7.4 Rest of Asia Pacific HVAC Controls Market Breakdown by End User
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiatives
13.3 New Product Development
13.4 Merger and Acquisition
14. Company Profiles
14.1 Carrier Global Corporation
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 DAIKIN INDUSTRIES, Ltd.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Delta Controls
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Acuity Brands, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Emerson Electric Co.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Honeywell International Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Johnson Controls, Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Schneider Electric SE
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Siemens AG
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Lennox International Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About
15.2 Word Index

LIST OF TABLES

Table 1. Neurostimulation Devices Market Segmentation
Table 2. North America Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 5. US Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 6. US Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. US Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 11. Mexico Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Europe Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Europe Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. Europe Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 17. Germany Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 18. Germany Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 19. Germany Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 20. UK Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 21. UK Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 22. UK Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 23. France Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 24. France Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25. France Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 26. Italy Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 27. Italy Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 28. Italy Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 29. Spain Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 30. Spain Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 31. Spain Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Europe Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Europe Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 35. Asia Pacific Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 36. Asia Pacific Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 37. Asia Pacific Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 38. China Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 39. China Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 40. China Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 41. Japan Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 42. Japan Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 43. Japan Neurostimulation Devices Market, by End User– Revenue and Forecast to 2030 (US$ Million)
Table 44. India Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 45. India Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 46. India Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 47. Australia Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 48. Australia Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 49. Australia Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 50. South Korea Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 51. South Korea Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 52. South Korea Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 53. Rest of Asia Pacific Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 54. Rest of Asia Pacific Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 55. Rest of Asia Pacific Neurostimulation Devices Market, by End User– Revenue and Forecast to 2030 (US$ Million)
Table 56. Middle East & Africa Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 57. Middle East & Africa Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 58. Middle East & Africa Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 59. Saudi Arabia Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 60. Saudi Arabia Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 61. Saudi Arabia Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 62. South Africa Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 63. South Africa Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 64. South Africa Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 65. UAE Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 66. UAE Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 67. UAE Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 68. Rest of Middle East & Africa Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 69. Rest of Middle East & Africa Neurostimulation Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 70. Rest of Middle East & Africa Neurostimulation Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 71. South & Central America Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 72. South & Central America: Neurostimulation Devices Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 73. South & Central America: Neurostimulation Devices Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 74. Brazil Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 75. Brazil: Neurostimulation Devices Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 76. Brazil: Neurostimulation Devices Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 77. Argentina Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 78. Argentina: Neurostimulation Devices Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 79. Argentina: Neurostimulation Devices Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 80. Rest of South & Central Neurostimulation Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 81. Rest of South & Central America: Neurostimulation Devices Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 82. Rest of South & Central America: Neurostimulation Devices Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 83. Organic Developments Done by Companies
Table 84. Inorganic Developments Done by Companies
Table 85. Glossary of Terms, Neurostimulation Devices Market

LIST OF FIGURES

Figure 1. Neurostimulation Devices Market Segmentation, By Geography
Figure 2. Global – PEST Analysis
Figure 3. Neurostimulation Devices Market: Key Industry Dynamics
Figure 4. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
Figure 5. Neurostimulation Devices Market Revenue (US$ Mn), 2020 – 2030
Figure 6. Global Neurostimulation Devices Market, By Geography Forecast Analysis, 2022 & 2030
Figure 7. Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. Spinal Cord Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Deep Brain Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Sacral Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Vagus Nerve Stimulator: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Pain Management: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Urinary and Fecal Incontinence: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Parkinson’s Disease: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 20. Hospitals & Clinics: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Neurostimulation Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. North America Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 26. US: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Canada: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Mexico: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe: Neurostimulation Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. Europe Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 32. Germany: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. UK: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. France: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Italy: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Spain: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Rest of Europe: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. Asia Pacific: Neurostimulation Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 39. Asia Pacific Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 41. China: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. Japan: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. India: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 44. Australia: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 45. South Korea: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 46. Rest of Asia Pacific: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 47. Middle East & Africa: Neurostimulation Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 48. Middle East & Africa Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 49. Middle East & Africa: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 50. Saudi Arabia: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 51. South Africa: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. UAE: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 53. Rest of Middle East & Africa: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 54. South & Central America: Neurostimulation Devices Market, By Key Country – Revenue (2022) (US$ Million)
Figure 55. South & Central America: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 56. South & Central America: Neurostimulation Devices Market Share by Country – 2022 & 2030, (%)
Figure 57. Brazil: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 58. Argentina: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 59. Rest of South & Central America: Neurostimulation Devices Market – Revenue and Forecast to 2030 (US$ Million)

The List of Companies – Neurostimulation Devices Market
– Medtronic Plc
– Boston Scientific Corp
– Abbott Laboratories
– Nevro Corp
– LivaNova Plc
– Synapse Biomedical Inc
– Nalu Medical, Inc
– ElectroCore Inc
– MicroTransponder Inc
– Mainstay Medical

Reviews

There are no reviews yet.

Be the first to review “Neurostimulation Devices Market Size and Forecasts (2020 – 2030)”